Fujifilm Diosynth Biotechnologies UK Limited
Customers
1
1 disclosed
Suppliers
0
None disclosed
Largest customer
—
No % disclosed
Named-customer revenue
—
No estimate available
Latest period
Dec 31, 2025
20-F filed 2026-02-11
How this is estimated
Dollars are the disclosed share × the discloser's revenue for that period, using the latest full year where available, or federal dollars obligated. Each side has its own scale.Customers 1
Companies that buy from Fujifilm Diosynth Biotechnologies UK Limited, as either company disclosed it. Percentages are a share of Fujifilm Diosynth Biotechnologies UK Limited revenue. 1 active, 0 lapsed.
| Company | % of Fujifilm Diosynth Biotechnologies UK Limited revenue | Est. revenue | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| ASND Ascendis Pharma A/S |
Named | — | FY 2025-12-31 | — | Active | 20-F 2026-02-11 |
Our growth hormone parent drug as well as our TransCon hGH drug substance are supplied by both Fujifilm Diosynth Biotechnologies UK Limited (“Fujifilm”), and Lonza Ltd. Our PTH as well as our TransCon PTH drug substance is supplied by Bachem, Switzerland, pursuant to our agreement with Bachem. | ||||||
Alerts are coming
Get an email when Fujifilm Diosynth Biotechnologies UK Limited's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.